#MedicalInnovation Archives

AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

By Lisa Cui 2024.12.26

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise globally, driven by the increasing rates of obesity and metabolic syndrome. Epidemiological studies indicate that by 2019, the…

Dr. Sizhou Feng’s Team Breakthroughs: Identifying Infection Risk Factors and Optimizing Differential Diagnosis Strategies for Hematological Patients

By Ren Jiamo 2024.12.26

Editorial Note: Neutropenia, immunosuppressive treatments, and various other factors make patients with hematological disorders particularly susceptible to infections from diverse pathogens. These infections often progress rapidly, with high mortality rates,…

AASLD 2024: Dr. Mingqin Lu’s Team Presents Study on Biomimetic Exosomes Loaded with Iridium Nanozyme for Acute Liver Failure Treatment

By Mourabit Halima 2024.12.17

At the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, Professor Mingqin Lu’s team from The First Affiliated Hospital of Wenzhou Medical University unveiled their latest…

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

By Mourabit Halima 2024.11.21

From November 15–19, 2024, the American Association for the Study of Liver Diseases (AASLD) convened in San Diego, USA. A study led by Dr. Huiguo Ding’s team from the Beijing…

Collaboration in HPB Health: Highlights from the 9th Academic Symposium of the Chinese Chapter of IHPBA

By Mourabit Halima 2024.11.14

The 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA) concluded successfully, underscoring major strides in global HPB collaboration. Hosted by Dr. Lanfei Cheng, the symposium…

2024 CACA丨 How to Balance Hepatic Adjuvant Therapy? Dr. Minshan Chen Shares Advances and Strategies in Liver Cancer Adjuvant Treatment

By Peng Longmei 2024.10.09

Hepatocellular carcinoma (HCC), often called the "king of cancers," not only has a low survival rate in advanced stages but also carries a high risk of postoperative recurrence, with a…

A Novel Magnetic Nanoparticle-Based Rapid Drug Sensitivity Testing Method Achieves 95% Consistency

By Mourabit Halima 2024.09.09

Editor’s note: Before clinicians can identify the pathogen causing sepsis and begin targeted antimicrobial therapy, they must wait for blood culture results, which typically take 2 to 3 days. However,…

Interventional Therapy in Hepatobiliary Diseases丨Dr. Xuefeng Luo: In-Depth Analysis of the French Guidelines on Transjugular Intrahepatic Portosystemi

By Mourabit Halima 2024.08.29

Editor's Note: Interventional therapy is an emerging clinical discipline that forms a crucial part of minimally invasive medicine, standing alongside traditional internal medicine and surgery as a key clinical specialty.…

EAU24 Interview丨Dr. Vasileios Sakalis：The value of artificial intelligence in the diagnosis and treatment of urinary tumors

By Mourabit Halima 2024.04.29

Editor's note: Artificial intelligence (AI) is changing the diagnosis and treatment model of urological tumors, especially in terms of intelligent imaging and intelligent pathology, and is expected to become a…

Pediatric-Inspired Therapy Revolutionizes Treatment of Adult Acute Lymphoblastic Leukemia: Insights from a Groundbreaking Chinese Study

By Mourabit Halima 2024.03.15

Introduction: Acute lymphoblastic leukemia (ALL) poses significant challenges in adult patient care, necessitating innovative treatment strategies. Addressing this need, a pioneering study conducted in China investigated the efficacy and safety…